Mangoceuticals (MGRX) Share-based Compensation (2023 - 2026)
Mangoceuticals (MGRX) reported Share-based Compensation of $589107.0 for Q1 2026, down 69.61% on a YoY basis from $1.9 million in Q1 2025, and down 93.81% sequentially from $9.5 million in Q4 2025.
Mangoceuticals (MGRX) Share-based Compensation (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Share-based Compensation data on file, last reported at $589107.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 69.61% year-over-year to $589107.0; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 335.85% YoY), and the FY2025 full-year result was $10.7 million, up 4209.4% from the prior year.
- Share-based Compensation retreated to $589107.0 in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $9.5 million in Q4 2025 to a low of -$3.9 million in Q3 2025.
- A 4-year average of $985744.1 and a median of $429079.0 in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation tumbled 434.4% in 2024 and surged 6128.11% in 2025, its largest moves.
- Tracing MGRX's Share-based Compensation over 4 years: stood at $429079.0 in 2023, then plunged by 434.4% to -$1.4 million in 2024, then surged by 763.14% to $9.5 million in 2025, then sank by 93.81% to $589107.0 in 2026.
- Business Quant data shows MGRX's Share-based Compensation at $589107.0 in Q1 2026, $9.5 million in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 119.26 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 3.68 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 19.41 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 8.29 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 22.64 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 8.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 11.45 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 36.74 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 21.92 Mn |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | 589,107.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 589,107.00 |
| Mar 31, 2026 | 589,107.00 |
| Dec 31, 2025 | 9.51 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 50,980.00 |
| Jun 30, 2024 | 50,980.00 |
| Mar 31, 2024 | 37,965.00 |
| Mar 31, 2024 | 37,965.00 |
| Dec 31, 2023 | 429,079.00 |
| Dec 31, 2023 | 429,079.00 |